IIM
Ipswich Investment Management Portfolio holdings
AUM
$414M
This Quarter Return
-16.55%
1 Year Return
+15.04%
3 Year Return
+70.41%
5 Year Return
+132.95%
10 Year Return
+315.52%
AUM
$254M
AUM Growth
+$254M
(-25%)
Cap. Flow
-$20.8M
Cap. Flow
% of AUM
-8.18%
Top 10 Holdings %
Top 10 Hldgs %
30.03%
Holding
183
New
3
Increased
32
Reduced
92
Closed
24
Top Buys
| 1 |
Coca-Cola
KO
|
$1.61M |
| 2 |
Watsco
WSO
|
$289K |
| 3 |
Crown Castle
CCI
|
$279K |
| 4 |
British American Tobacco
BTI
|
$205K |
| 5 |
Pfizer
PFE
|
$177K |
Top Sells
| 1 |
Marriott International Class A Common Stock
MAR
|
$1.3M |
| 2 |
Johnson & Johnson
JNJ
|
$1.01M |
| 3 |
Ares Capital
ARCC
|
$1M |
| 4 |
RTX Corp
RTX
|
$795K |
| 5 |
Chubb
CB
|
$776K |
Sector Composition
| 1 | Technology | 20.47% |
| 2 | Healthcare | 17.57% |
| 3 | Consumer Staples | 15.02% |
| 4 | Industrials | 11.78% |
| 5 | Financials | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
3M
MMM
$82.8B
| $3.02M | 1.19% |
22,153
+74
| +0.3% | +$10.1K |
|
27
Texas Instruments
TXN
$184B
| $3M | 1.18% |
30,021
-1,970
| -6% | -$197K |
|
28
PepsiCo
PEP
$204B
| $3M | 1.18% |
24,948
-1,425
| -5% | -$171K |
|
29
AbbVie
ABBV
$372B
| $2.96M | 1.16% |
38,859
+154
| +0.4% | +$11.7K |
|
30
Linde
LIN
$224B
| $2.91M | 1.14% |
16,795
-765
| -4% | -$132K |
|
31
Illinois Tool Works
ITW
$77.1B
| $2.8M | 1.1% |
19,689
-1,640
| -8% | -$233K |
|
32
Marsh & McLennan
MMC
$101B
| $2.8M | 1.1% |
32,333
-2,190
| -6% | -$189K |
|
33
Church & Dwight Co
CHD
$22.7B
| $2.76M | 1.08% |
42,927
-315
| -0.7% | -$20.2K |
|
34
Abbott
ABT
$231B
| $2.75M | 1.08% |
34,900
-1,530
| -4% | -$121K |
|
35
Baxter International
BAX
$12.7B
| $2.7M | 1.06% |
33,285
-325
| -1% | -$26.4K |
|
36
Lockheed Martin
LMT
$106B
| $2.59M | 1.02% |
7,641
+98
| +1% | +$33.2K |
|
|
37
Watsco
WSO
$16.3B
| $2.38M | 0.94% |
15,062
+1,827
| +14% | +$289K |
|
|
RDS.A
38
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.26M | 0.89% |
64,750
-3,709
| -5% | -$129K |
|
39
Novartis
NVS
$245B
| $2.2M | 0.86% |
26,663
-2,700
| -9% | -$223K |
|
40
Duke Energy
DUK
$95.3B
| $2.17M | 0.85% |
26,797
-755
| -3% | -$61.1K |
|
|
41
Chubb
CB
$110B
| $2.15M | 0.85% |
19,281
-6,950
| -26% | -$776K |
|
42
Akamai
AKAM
$11.3B
| $2.1M | 0.83% |
23,001
+410
| +2% | +$37.5K |
|
43
Walt Disney
DIS
$213B
| $1.95M | 0.77% |
20,210
-1,350
| -6% | -$130K |
|
44
McDonald's
MCD
$224B
| $1.94M | 0.76% |
11,738
-191
| -2% | -$31.6K |
|
45
AT&T
T
$209B
| $1.93M | 0.76% |
66,279
-255
| -0.4% | -$7.43K |
|
46
Thermo Fisher Scientific
TMO
$186B
| $1.92M | 0.76% |
6,773
-968
| -13% | -$275K |
|
47
CRISPR Therapeutics
CRSP
$4.71B
| $1.74M | 0.68% |
40,915
-2,325
| -5% | -$98.6K |
|
48
Colgate-Palmolive
CL
$67.9B
| $1.71M | 0.67% |
25,693
-175
| -0.7% | -$11.6K |
|
49
IBM
IBM
$227B
| $1.57M | 0.62% |
14,114
+300
| +2% | +$33.3K |
|
50
Citizens Financial Group
CFG
$22.6B
| $1.56M | 0.61% |
82,670
-9,450
| -10% | -$178K |
|